|
EP0813065A3
(en)
*
|
1996-06-13 |
1998-07-22 |
F. Hoffmann-La Roche Ag |
Modulation of LC132 (opioid-like) receptor function
|
|
CA2206192A1
(en)
|
1996-06-13 |
1997-12-13 |
F. Hoffmann-La Roche Ag |
Modulation of lc132 (opioid-like) receptor function
|
|
AU8333998A
(en)
*
|
1997-07-15 |
1999-02-10 |
Novo Nordisk A/S |
New use of nociceptin
|
|
WO1999003880A1
(en)
*
|
1997-07-15 |
1999-01-28 |
Novo Nordisk A/S |
Nociceptin analogues
|
|
US5929035A
(en)
*
|
1998-04-14 |
1999-07-27 |
Regents Of The University Of Michigan |
Methods of treating intestinal disorders
|
|
GB9815618D0
(en)
*
|
1998-07-18 |
1998-09-16 |
Univ Manchester |
Treatment of dyskinesia
|
|
MA26659A1
(fr)
|
1998-08-06 |
2004-12-20 |
Pfizer |
Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
|
|
US6582457B2
(en)
*
|
2001-02-15 |
2003-06-24 |
Radiant Medical, Inc. |
Method of controlling body temperature while reducing shivering
|
|
US6849449B2
(en)
*
|
2001-03-01 |
2005-02-01 |
Regents Of The University Of Michigan |
Orphanin FQ receptor nucleic acids
|
|
US20030040479A1
(en)
*
|
2001-07-02 |
2003-02-27 |
Omeros Corporation |
Rotational intrathecal analgesia method and device
|
|
EP1406629A1
(en)
*
|
2001-07-02 |
2004-04-14 |
Omeros Corporation |
Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump
|
|
WO2003030828A2
(en)
*
|
2001-10-09 |
2003-04-17 |
Synvax, Inc. |
Nociceptin-based analgesics
|
|
ES2348604T3
(es)
*
|
2002-04-29 |
2010-12-09 |
Euro-Celtique S.A. |
Péptidos conformacionalmente restringidos que se unen al receptor orl-1.
|
|
AU2003257111A1
(en)
*
|
2002-08-02 |
2004-02-23 |
Incyte Corporation |
Extracellular messengers
|
|
EA009369B1
(ru)
|
2002-09-09 |
2007-12-28 |
Янссен Фармацевтика, Н.В. |
Производные гидроксизамещенного 1,3,8-триазинспиро[4,5]декан-4-она, полезные для лечения расстройств, опосредованных orl-рецептором
|
|
BRPI0409133B8
(pt)
|
2003-04-08 |
2021-05-25 |
Progenics Pharm Inc |
preparações farmacêuticas estavéis compreendendo metilnaltrexona
|
|
US7173010B2
(en)
*
|
2003-05-19 |
2007-02-06 |
Regents Of The University Of Michigan |
Orphanin FQ receptor
|
|
US8524731B2
(en)
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
BRPI0608818A2
(pt)
|
2005-03-07 |
2010-01-26 |
Univ Chicago |
uso de antagonista opióides para atenuação de proliferação e migração de células endoteliais
|
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
|
US9662325B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
WO2006130416A2
(en)
|
2005-06-02 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
Novel 3-spirocyclic indolyl derivatives useful as orl-1 receptor modulators
|
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
|
MX2009005641A
(es)
|
2006-11-28 |
2009-06-05 |
Janssen Pharmaceutica Nv |
Sales de 3-(3-amino-2-(r)-hidroxi-propil)-1-(4-fluoro-fenil)-8-(8- metil-naftalen-1-ilmetil)-1,3,8-triaza-espiro[4,5]deca n-4-ona.
|
|
EP2134718A2
(en)
|
2007-03-29 |
2009-12-23 |
Progenics Pharmaceuticals, Inc. |
Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
|
|
PT2139890E
(pt)
|
2007-03-29 |
2014-09-03 |
Wyeth Llc |
Antagonistas do receptor opióide periférico e respectivas utilizações
|
|
CA2682125C
(en)
|
2007-03-29 |
2015-06-16 |
Progenics Pharmaceuticals, Inc. |
Peripheral opioid receptor antagonists and uses thereof
|
|
CN101679430B
(zh)
|
2007-04-09 |
2013-12-25 |
詹森药业有限公司 |
用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
|
|
JP2010527980A
(ja)
|
2007-05-22 |
2010-08-19 |
プロシディオン・リミテッド |
代謝障害を治療するための二環状アリールおよびヘテロアリール化合物
|
|
US8063247B2
(en)
|
2007-09-07 |
2011-11-22 |
Prosidion Limited |
Bicyclic aryl and heteroaryl receptor modulators
|
|
CA2713568C
(en)
|
2008-02-06 |
2016-09-20 |
Progenics Pharmaceuticals, Inc. |
Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
|
|
AU2009225434B2
(en)
|
2008-03-21 |
2014-05-22 |
The University Of Chicago |
Treatment with opioid antagonists and mTOR inhibitors
|
|
CA2676881C
(en)
|
2008-09-30 |
2017-04-25 |
Wyeth |
Peripheral opioid receptor antagonists and uses thereof
|
|
RU2492482C1
(ru)
*
|
2012-10-08 |
2013-09-10 |
Игорь Петрович Папышев |
Способ диагностики причины смерти от интоксикации наркотическими веществами группы опиатов
|